Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yumi Murakami is active.

Publication


Featured researches published by Yumi Murakami.


European Journal of Pediatrics | 2007

Potential use of procalcitonin concentrations as a diagnostic marker of the PFAPA syndrome

Takao Yoshihara; Toshihiko Imamura; Kentaro Yokoi; Mayumi Shibata; Gen Kano; Shinya Osone; Kanae Yagi; Shinjiro Todo; Yumi Murakami; Yuichi Yamada; Hiroyuki Yamada; Shinji Satomura; Hiroyuki Ishida

PFAPA syndrome is a clinical entity of unknown etiology characterized by periodic episodes of high fever accompanied by aphthous stomatitis, pharyngitis/tonsillitis, and cervical adenitis [3, 5]. Since specific laboratory abnormalities for the PFAPA syndrome are inexistent, it is usually diagnosed clinically after excluding other probable causes of the fever, such as infection [1]. In PFAPA patients, discriminating between a fever attack due to bacterial infection and a fever attack due to noninfectious inflammation constitutes a major difficulty. Because procalcitonin, a propeptide of calcitonin, is reported to be a sensitive marker of systemic bacterial infection [2, 4], we followed peripheral leukocyte counts, CRP values and procalcitonin concentrations during the fever attacks associated with PFAPA syndrome in the hope of defining reliable criteria for its diagnosis. We determined serum procalcitonin concentrations in six PFAPA syndrome patients (two males and four females) with a median age of 7.5 (range 3–10) years and in 32 controls (bacterial, n=10 and non-bacterial, n=22). Sampling was performed on the third to fifth day of fever. In the PFAPA syndrome patients, febrile episodes started at the median age of 2.5 (range 1–7) years with each episode lasting 5–7 days and recurring every 3–4 weeks. The ethical committees of our institutes approved the study protocol and the guardians of all the patients gave their informed consent. Serum procalcitonin concentrations were measured by using the fully automated enzyme immunoluminescent assay (Wako Pure Chemical Industries, Ltd.), which employs katacalcin monoclonal antibody and calcitonin polyclonal antibody labeled with peroxidase for SphereLight 180 (Olympus Corporation). The detection limit was 0.1 ng/ml and the normal reference was set at <0.5 ng/ml. In PFAPA patients, the correlations between procalcitonin, CRP values and leukocyte counts were examined over 13 febrile episodes. Serum procalcitonin values ranged from 0.20 to 11.36 (median value 1.05) ng/ml in positive control subjects (Table 1), while all the negative controls had undetectable levels. During febrile episodes in PFAPA patients, which were confirmed not to be due to adenoviral or group A streptococcal infections, leukocyte counts and serum concentrations of CRP were invariably and significantly Eur J Pediatr (2007) 166:621–622 DOI 10.1007/s00431-006-0281-2


Archive | 1995

Virtual space apparatus with avatars and speech

Gen Suzuki; Shohei Sugawara; Hiroya Tanigawa; Machio Moriuchi; Yoshio Nagashima; Yasuhiro Nakajima; Hiroyuki Arita; Yumi Murakami


Archive | 1995

Shared virtual space display method and apparatus using said method

Gen Suzuki; Shohei Sugawara; Hiroya Tanigawa; Machio Moriuchi; Yoshio Nagashima; Yasuhiro Nakajima; Hiroyuki Arita; Yumi Murakami


Archive | 2000

Multimedia conference service providing system of telephone using type

Masaru Ando; Toru Ishihara; Masao Masugi; Yumi Murakami; Yoshio Nagashima; Hitoshi Sato; Kotaro Shinkawa; 仁 佐藤; 大 安藤; 晃太郎 新川; 由美 村上; 美雄 永嶋; 徹 石原; 正男 馬杉


Archive | 2000

MULTIMEDIA CONFERENCE SERVICE SUPPLY SYSTEM

Masaru Ando; Toru Ishihara; Masao Masugi; Yumi Murakami; Yoshio Nagashima; Hitoshi Sato; Kotaro Shinkawa; 仁 佐藤; 大 安藤; 晃太郎 新川; 由美 村上; 美雄 永嶋; 徹 石原; 正男 馬杉


Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2010

Effect of pitavastatin on serum high-molecular weight (HMW) adiponectin to total adiponectin ratio in type 2 diabetic patients

Keiji Yoshioka; Yumi Murakami; Kyoko Ego; Yasuhiro Nakajima


Archive | 2004

CONTENT INFORMATION DISPLAY SUPPORT METHOD, DEVICE, AND PROGRAM, AND STORAGE MEDIUM WITH PROGRAM STORED THEREON

Harumi Kawashima; Yumi Murakami; Masakatsu Okubo; Tsutomu Sasaki; 努 佐々木; 雅且 大久保; 晴美 川島; 由美 村上


Archive | 1995

Anzeigeverfahren für einen gemeinsamen virtuellen Raum und Vorrichtung unter Verwendung dieses Verfahrens

Gen Suzuki; Shohei Sugawara; Hiroya Tanigawa; Machio Moriuchi; Yoshio Nagashima; Yasuhiro Nakajima; Hiroyuki Arita; Yumi Murakami


Archive | 2008

Article trust level calculator, calculating method, program and recording medium

Harumi Kawashima; Yumi Murakami; Hidenori Okuda; 英範 奥田; 晴美 川島; 由美 村上


Journal of medical technology | 2008

Evaluation of self monitoring of blood ketones by an electrochemical sensor in Type 1 diabetes patients

Yasuhito Nakajima; Kyoko Ego; Yumi Murakami; Keiji Yoshioka

Collaboration


Dive into the Yumi Murakami's collaboration.

Top Co-Authors

Avatar

Yasuhiro Nakajima

Memorial Hospital of South Bend

View shared research outputs
Top Co-Authors

Avatar

Gen Suzuki

National Institute of Radiological Sciences

View shared research outputs
Top Co-Authors

Avatar

Keiji Yoshioka

Memorial Hospital of South Bend

View shared research outputs
Top Co-Authors

Avatar

Kyoko Ego

Memorial Hospital of South Bend

View shared research outputs
Top Co-Authors

Avatar

Hiroyuki Ishida

Memorial Hospital of South Bend

View shared research outputs
Top Co-Authors

Avatar

Kentaro Yokoi

Memorial Hospital of South Bend

View shared research outputs
Top Co-Authors

Avatar

Takao Yoshihara

Memorial Hospital of South Bend

View shared research outputs
Top Co-Authors

Avatar

Yuichi Yamada

Memorial Hospital of South Bend

View shared research outputs
Top Co-Authors

Avatar

Gen Kano

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Kanae Yagi

Kyoto Prefectural University of Medicine

View shared research outputs
Researchain Logo
Decentralizing Knowledge